Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.
Peeters H, Louis E, Baert F, Dewit O, Coche JC, Ferrante M, Lambrecht G, Colard A, Van Gossum A, Bossuyt P, Moreels T, Vander Cruyssen B, Gils A, De Vos M.
Peeters H, et al. Among authors: bossuyt p.
Acta Gastroenterol Belg. 2018 Jan-Mar;81(1):15-21.
Acta Gastroenterol Belg. 2018.
PMID: 29562373
Free article.